SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

Equity Bottom-Up

<ul><li>Over 70 SGX primary-listed companies repurchased S$2.09 billion in shares in 8M26, up from S$1.57 billion in 8M25.</li><li>Singtel led with S$948.6 million in buybacks, aiming for a 3% EPS accretion through its S$2 billion programme.</li><li>Seatrium's buybacks reached S$99.7 million, nearing full deployment of its S$100 million programme since 2024.</li></ul>

Over 70 SGX primary-listed companies repurchased S$2.09 billion in shares in 8M26, up from S$1.57 billion in 8M25.Singtel led with S$948.6 million in buybacks, aiming for a 3% EPS accretion through its S$2 billion programme.Seatrium's buybacks reached S$99.7 million, nearing full deployment of its S$100 million programme since 2024.

2026 Buyback Consideration Surpasses S$2 Billion

<ul><li>Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks.</li><li>Soon Hock Enterprise's Executive Chairman increased his direct interest to 73.32% with a purchase of 2,033,000 shares.</li><li>Lum Chang Creations entered a placement agreement for up to 35 million shares, raising up to S$11.4 million.</li></ul>

Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks.Soon Hock Enterprise's Executive Chairman increased his direct interest to 73.32% with a purchase of 2,033,000 shares.Lum Chang Creations entered a placement agreement for up to 35 million shares, raising up to S$11.4 million.

Director Accumulation Extends Across Established and Newly Listed Counters

<ul><li>Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme.</li><li>Ho Bee Holdings acquired 334,700 shares, raising Chua Thian Poh’s deemed interest from 75.737% to 75.788%.</li><li>Nam Cheong's 1QFY26 PATMI increased 160% to RM78.9 million, with net gearing reduced to 0.17 times.</li></ul>

Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme.Ho Bee Holdings acquired 334,700 shares, raising Chua Thian Poh’s deemed interest from 75.737% to 75.788%.Nam Cheong's 1QFY26 PATMI increased 160% to RM78.9 million, with net gearing reduced to 0.17 times.

Ho Bee chair ups stake; M&G becomes substantial unitholder in NetLink NBN Trust

Singapore

UltraGreen.ai is a global leader in fluorescence-guided surgery (FGS), specializing in the development, contracted manufacture, and commercialization of indocyanine green (ICG) fluorescence agents. The company also provides the IC-Flow Imaging System and the UltraGreen Data Platform, which incorporates AI-powered PerfusionWorks quantification software for real-time surgical insights. Headquartered in Singapore, the company was incorporated in 2024.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

UltraGreen.ai (UGAI SP)

2026 Buyback Consideration Surpasses S$2 Billion

Over 70 SGX primary-listed companies repurchased S$2.09 billion in shares in 8M26, up from S$1.57 billion in 8M25. Singtel led with S$948.6...

Singapore Exchange Ltd (SGX)

Director Accumulation Extends Across Established and Newly Listed Counters

Over five sessions to 25 June, directors and CEOs reported 21 acquisitions and five disposals across 30 primary-listed stocks. Soon Hock...

Singapore Exchange Ltd (SGX)

Ho Bee chair ups stake; M&G becomes substantial unitholder in NetLink NBN Trust

Singapore Telecommunications led buybacks with 13.3 million shares at S$4.33 under a S$2 billion programme. Ho Bee Holdings acquired 334,700...

Singapore Exchange Ltd (SGX)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)